等待開盤 02-07 09:30:00 美东时间
+12.830
+2.48%
今日重点评级关注:Benchmark:维持Charter Communications"买入"评级,目标价从425美元升至455美元;BTIG:维持LifeStance Health Gr"买入"评级,目标价从10美元升至11美元
02-03 09:06
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
U.S. RESEARCH ROUNDUP- AGNC Investment, Brown & Brown, Korro Bio Jan 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AGNC Investment, Brown & Brown and Korro Bio on Thursday. HIGHLIGHTS * AGNC Investment Corp AGNC.O :
01-29 15:54
华盛资讯1月29日讯,雷诺士公布2025财年Q4业绩,公司Q4营收11.95亿美元,同比下降11.2%,归母净利润1.43亿美元,同比下滑29.2%。
01-29 03:01
BUZZ-U.S. STOCKS ON THE MOVE-Amneal Pharma, Ardelyx, Snap Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 crossed the 7,000 mark for the first time on Wednesday and the N
01-28 23:48
Lennox International shares are trading lower after the company reported worse-...
01-28 21:59
Lennox Q4 revenue misses on Home Comfort Solutions unit weakness Overview Climate-control solutions firm's Q4 revenue declined 11%, missing analyst expectations Adjusted EPS for Q4 decreased by 22% Company attributes revenue decline to unfavorable sales volumes and macroeconomic uncertainties Outloo
01-28 19:54
Lennox Q4 adjusted diluted EPS USD 4.45 down 22% Lennox International Inc. reported its fourth quarter (Q4) and full year (FY) 2025 financial results. For Q4 2025, the company posted revenue of USD 1.2 billion and operating income of USD 196 million. Segment profit was USD 212 million, while GAAP di
01-28 19:46
BRIEF-Lennox International Q4 Adjusted EPS USD 4.07 Vs. IBES Estimate USD 4.75 Jan 28 (Reuters) - Lennox International Q4 EPS USD 4.07. Q4 revenue USD 1,195 million vs. IBES estimate USD 1,273 million
01-28 19:45
Companies Reporting Before The Bell • VF (NYSE:VFC) is estimated to report quar...
01-28 19:11